Free Trial
→ Elon’s Terrifying Warning Forces Trump To Take Action (From American Hartford Gold) (Ad) Buy AGX Stock  Free AGX Stock Alerts

Argan (AGX) Financials

Argan logo
$163.76 +4.96 (+3.12%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$162.76 -1.01 (-0.61%)
As of 05/2/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Argan

Annual Income Statements for Argan

This table shows Argan's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/31/2015 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 30 36 70 72 52 -43 24 38 33 32 85
Consolidated Net Income / (Loss)		 43 50 77 72 52 -41 24 36 35 32 85
Net Income / (Loss) Continuing Operations		 43 50 77 72 52 -41 24 36 35 32 85
Total Pre-Tax Income 		64 76 115 113 47 -48 25 47 46 49 111
Total Operating Income		 64 74 112 107 40 -56 23 45 42 36 88
Total Gross Profit		 84 99 147 149 82 -6.82 62 100 86 81 141
Total Revenue		 383 413 675 893 482 239 392 509 455 573 874
Operating Revenue		 383 413 675 893 482 239 392 509 455 573 874
Total Cost of Revenue		 300 314 528 743 400 246 330 410 369 492 733
Operating Cost of Revenue		 300 314 528 743 400 246 330 410 369 492 733
Total Operating Expenses		 19 25 34 42 42 49 39 55 45 44 53
Selling, General & Admin Expense		 19 25 32 42 41 44 39 47 45 44 53
Total Other Income / (Expense), net		 0.23 1.10 2.28 5.65 6.98 8.08 1.86 2.55 4.33 12 23
Other Income / (Expense), net		 0.23 1.10 2.28 5.65 6.98 8.08 1.86 2.55 4.33 12 23
Income Tax Expense		 21 25 37 40 -4.65 -7.05 1.07 11 11 17 26
Net Income / (Loss) Attributable to Noncontrolling Interest		 13 14 7.10 0.34 -0.17 1.98 -0.04 -2.54 1.61 0.00 0.00
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 - - - - - - - 0.00 0.00 -0.20 0.62
Basic Earnings per Share		 $2.11 $2.46 $4.67 $4.64 $3.34 ($2.73) $1.52 $2.43 $2.35 $2.42 $6.35
Weighted Average Basic Shares Outstanding		 14.43M 14.76M 15.07M 15.52M 15.57M 15.62M 15.67M 15.72M 14.08M 13.37M 13.45M
Diluted Earnings per Share		 $2.05 $2.42 $4.50 $4.56 $3.32 ($2.73) $1.51 $2.40 $2.33 $2.39 $6.15
Weighted Average Diluted Shares Outstanding		 14.82M 15.02M 15.63M 15.78M 15.69M 15.62M 15.83M 15.91M 14.18M 13.55M 13.91M
Weighted Average Basic & Diluted Shares Outstanding		 14.40M 14.80M 15.10M 15.50M 15.60M 15.64M 15.72M 14.82M 13.40M 13.24M 13.63M
Cash Dividends to Common per Share		 $0.70 $0.70 $1.00 $1.00 $1.00 $1.00 $3.00 $1.00 $1.00 $1.10 $1.35

Quarterly Income Statements for Argan

This table shows Argan's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 7/31/2022 10/31/2022 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 3.54 7.11 15 2.51 12 4.16 14 6.12 19 26 33
Consolidated Net Income / (Loss)		 4.22 7.76 15 2.11 13 5.46 12 7.88 18 28 31
Net Income / (Loss) Continuing Operations		 4.22 7.76 15 2.11 13 5.46 12 7.88 18 28 31
Total Pre-Tax Income 		14 10 12 3.00 17 12 17 11 24 37 39
Total Operating Income		 13 9.54 9.56 3.63 13 7.86 12 6.52 19 30 33
Total Gross Profit		 24 22 20 14 24 19 24 18 31 44 48
Total Revenue		 118 118 119 104 141 164 165 158 227 257 232
Operating Revenue		 118 118 119 104 141 164 165 158 227 257 232
Total Cost of Revenue		 94 96 99 89 118 145 141 140 196 213 185
Operating Cost of Revenue		 94 96 99 89 118 145 141 140 196 213 185
Total Operating Expenses		 11 13 10 11 11 11 12 11 12 14 15
Selling, General & Admin Expense		 11 13 10 11 11 11 12 11 12 14 15
Total Other Income / (Expense), net		 0.51 0.77 2.46 -0.63 4.12 3.73 5.25 4.79 5.60 6.65 5.97
Other Income / (Expense), net		 0.51 0.77 2.46 -0.63 4.12 3.73 5.25 4.79 5.60 6.65 5.97
Income Tax Expense		 9.69 2.55 -3.21 0.90 4.59 6.13 4.96 3.43 6.08 8.97 7.26
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 0.69 0.65 - -0.40 0.87 1.31 -1.97 1.76 -1.27 1.62 -1.48
Basic Earnings per Share		 $0.30 $0.56 $0.99 $0.16 $0.95 $0.41 $0.90 $0.59 $1.36 $2.07 $2.33
Weighted Average Basic Shares Outstanding		 14.13M 13.78M 14.08M 13.41M 13.40M 13.33M 13.37M 13.26M 13.40M 13.53M 13.45M
Diluted Earnings per Share		 $0.30 $0.56 $0.97 $0.16 $0.94 $0.40 $0.89 $0.58 $1.31 $2.00 $2.26
Weighted Average Diluted Shares Outstanding		 14.25M 13.81M 14.18M 13.55M 13.54M 13.56M 13.55M 13.57M 13.88M 14.03M 13.91M
Weighted Average Basic & Diluted Shares Outstanding		 13.88M 13.58M 13.40M 13.41M 13.32M 13.33M 13.24M 13.35M 13.50M 13.58M 13.63M
Cash Dividends to Common per Share		 $0.25 $0.25 $0.25 $0.25 $0.25 $0.30 $0.30 $0.30 $0.30 $0.38 $0.38

Annual Cash Flow Statements for Argan

This table details how cash moves in and out of Argan's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/31/2015 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Net Change in Cash & Equivalents		 61 -173 6.37 -48 43 3.05 199 -16 -177 23 -52
Net Cash From Operating Activities		 93 -33 259 -73 -112 54 176 28 -30 117 168
Net Cash From Continuing Operating Activities		 93 -33 259 -73 -112 54 176 28 -30 117 168
Net Income / (Loss) Continuing Operations		 43 50 77 72 52 -41 24 36 35 32 85
Consolidated Net Income / (Loss)		 43 50 77 72 52 -41 24 36 35 32 85
Depreciation Expense		 0.55 0.78 2.04 2.78 3.42 3.51 3.72 3.37 2.98 2.01 1.91
Amortization Expense		 0.24 0.53 1.16 1.03 1.01 1.14 0.90 0.87 2.55 1.91 3.76
Non-Cash Adjustments To Reconcile Net Income		 2.02 2.23 118 -131 -42 34 12 39 -16 -18 25
Changes in Operating Assets and Liabilities, net		 47 -87 60 -18 -127 56 136 -51 -54 99 51
Net Cash From Investing Activities		 -3.55 -131 -244 39 171 -36 67 -7.04 -63 -68 -194
Net Cash From Continuing Investing Activities		 -3.55 -131 -244 39 171 -36 67 -7.04 -63 -68 -194
Purchase of Property, Plant & Equipment		 -2.94 -3.12 -2.81 -4.83 -8.60 -7.06 -1.70 -1.42 -3.37 -2.76 -6.58
Acquisitions		 - -17 - - - 0.00 -1.33 -5.62 0.00 -5.11 -16
Purchase of Investments		 - -252 -595 -543 -191 -195 -100 -90 -250 -219 -315
Sale and/or Maturity of Investments		 - 138 354 588 370 166 170 90 190 160 149
Other Investing Activities, net		 -0.61 3.96 - -1.50 0.23 - - - 0.00 0.00 -5.02
Net Cash From Financing Activities		 -28 -8.65 -8.86 -14 -16 -14 -45 -35 -83 -26 -26
Net Cash From Continuing Financing Activities		 -28 -8.65 -8.86 -14 -16 -14 -45 -35 -83 -26 -26
Repurchase of Common Equity		 - - - - - 0.00 0.00 -20 -68 -12 -1.52
Payment of Dividends		 -35 -10 -25 -17 -16 -16 -47 -16 -15 -15 -18
Other Financing Activities, net		 6.87 1.73 16 3.16 0.10 1.63 1.64 1.43 0.07 1.10 -6.27
Effect of Exchange Rate Changes		 - -0.57 - - - -0.47 1.73 -2.97 -0.54 -0.12 0.32
Cash Income Taxes Paid		 19 26 37 44 - - - 14 6.67 14 31

Quarterly Cash Flow Statements for Argan

This table details how cash moves in and out of Argan's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 7/31/2022 10/31/2022 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025
Net Change in Cash & Equivalents		 -49 -7.28 38 22 8.85 -19 11 11 25 -57 -30
Net Cash From Operating Activities		 -17 -16 43 -1.25 36 58 25 18 73 32 45
Net Cash From Continuing Operating Activities		 -17 -16 43 -1.25 36 58 25 18 73 32 45
Net Income / (Loss) Continuing Operations		 4.22 7.76 15 2.11 13 5.46 12 7.88 18 28 31
Consolidated Net Income / (Loss)		 4.22 7.76 15 2.11 13 5.46 12 7.88 18 28 31
Depreciation Expense		 0.75 0.74 0.69 0.55 0.49 0.49 0.49 0.48 0.46 0.43 0.53
Amortization Expense		 0.23 0.21 1.94 0.10 0.10 0.10 1.61 0.10 0.10 0.10 3.46
Non-Cash Adjustments To Reconcile Net Income		 -0.61 -1.28 -13 21 -14 -2.87 -23 -4.38 11 3.65 15
Changes in Operating Assets and Liabilities, net		 -22 -24 38 -25 37 55 33 14 44 -0.41 -5.59
Net Cash From Investing Activities		 -0.40 23 -0.79 29 -20 -70 -5.72 -1.73 -43 -82 -67
Net Cash From Continuing Investing Activities		 -0.40 23 -0.79 29 -20 -70 -5.72 -1.73 -43 -82 -67
Purchase of Property, Plant & Equipment		 -0.40 -1.94 -0.79 -0.65 -0.39 -1.11 -0.61 -0.32 -2.35 -2.55 -1.37
Acquisitions		 - - - 0.00 - - -5.11 -3.31 - - -13
Purchase of Investments		 - -75 - -120 -30 -69 - -87 -55 -102 -70
Sale and/or Maturity of Investments		 - 100 - 150 10 - - 89 15 23 23
Net Cash From Financing Activities		 -30 -13 -9.03 -6.49 -6.00 -5.56 -8.00 -5.12 -5.56 -6.93 -8.45
Net Cash From Continuing Financing Activities		 -30 -13 -9.03 -6.49 -6.00 -5.56 -8.00 -5.12 -5.56 -6.93 -8.45
Repurchase of Common Equity		 -26 -10 -4.98 -3.68 -3.06 -1.73 -4.00 -0.19 - -0.46 -0.88
Payment of Dividends		 -3.48 -3.40 -4.05 -3.36 -3.34 -3.99 -4.00 -4.03 -4.04 -5.20 -5.01
Other Financing Activities, net		 - - - 0.54 0.40 0.16 -0.01 -0.91 -1.52 -1.28 -2.56
Effect of Exchange Rate Changes		 - - 4.77 0.99 -0.66 -1.04 0.59 -0.13 -0.15 0.10 0.51
Cash Income Taxes Paid		 - - 0.36 0.51 2.76 3.75 7.28 3.31 5.83 6.00 16

Annual Balance Sheets for Argan

This table presents Argan's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/31/2015 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Total Assets		 391 410 644 543 477 488 603 554 489 598 836
Total Current Assets		 364 351 588 485 416 422 546 507 439 547 781
Cash & Equivalents		 334 161 167 122 164 167 367 350 174 197 145
Short-Term Investments		 - 114 356 312 132 160 90 90 152 215 380
Accounts Receivable		 27 64 55 26 36 37 29 27 50 47 176
Other Current Assets		 0.46 4.08 3.19 25 84 57 61 40 63 87 80
Plant, Property, & Equipment, net		 6.52 12 13 15 20 23 20 10 10 11 14
Total Noncurrent Assets		 20 47 43 42 41 43 36 32 40 40 40
Goodwill		 18 37 35 34 33 28 28 28 28 28 28
Intangible Assets		 1.85 9.34 8.18 7.15 6.14 5.00 4.10 3.32 2.61 2.22 1.83
Noncurrent Deferred & Refundable Income Taxes		 - - 0.24 0.44 1.26 7.89 0.25 0.46 3.69 2.26 0.55
Other Noncurrent Operating Assets		 - 0.12 0.09 0.43 0.29 2.41 3.76 - 6.02 7.52 10
Total Liabilities & Shareholders' Equity		 391 410 644 543 477 488 603 554 489 598 836
Total Liabilities		 216 188 352 185 82 147 280 228 209 307 484
Total Current Liabilities		 215 188 351 183 81 144 276 223 203 302 480
Accounts Payable		 38 46 102 100 40 35 53 42 56 39 97
Accrued Expenses		 16 35 40 35 33 36 51 53 50 82 83
Other Current Liabilities		 - - - 48 8.35 73 172 128 96 181 299
Total Noncurrent Liabilities		 0.81 0.22 1.20 1.28 0.96 2.48 4.14 4.96 6.09 5.03 4.51
Other Noncurrent Operating Liabilities		 - - - - 0.96 2.48 4.14 - 6.09 5.03 4.51
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 175 222 293 358 394 341 322 326 281 291 352
Total Preferred & Common Equity		 185 219 292 358 395 339 321 326 281 291 352
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 185 219 292 358 395 339 321 326 281 291 352
Common Stock		 112 120 138 146 147 151 156 161 165 167 171
Retained Earnings		 74 100 155 211 248 189 166 189 208 226 293
Treasury Stock		 - - - - - - -0.03 -20 -89 -98 -106
Accumulated Other Comprehensive Income / (Loss)		 - -0.57 -0.76 1.42 -0.35 -1.12 -1.08 -2.45 -2.88 -3.60 -6.54

Quarterly Balance Sheets for Argan

This table presents Argan's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 10/31/2021 4/30/2022 7/31/2022 10/31/2022 4/30/2023 7/31/2023 10/31/2023 4/30/2024 7/31/2024 10/31/2024
Total Assets		 613 493 423 411 476 506 564 624 727 769
Total Current Assets		 560 448 378 365 425 455 514 574 675 717
Cash & Equivalents		 392 192 143 136 196 205 186 208 233 175
Short-Term Investments		 90 175 176 151 121 142 212 209 252 331
Accounts Receivable		 36 36 25 38 61 45 50 60 95 132
Other Current Assets		 42 44 34 40 47 64 67 98 95 79
Plant, Property, & Equipment, net		 18 9.94 9.51 11 11 10 11 11 12 14
Total Noncurrent Assets		 35 35 35 35 40 40 39 39 40 38
Goodwill		 28 28 28 28 28 28 28 28 28 28
Intangible Assets		 3.42 3.18 2.94 2.73 2.51 2.41 2.32 2.12 2.02 1.92
Noncurrent Deferred & Refundable Income Taxes		 0.00 4.08 4.40 4.67 3.61 3.91 3.13 2.31 1.64 1.25
Other Noncurrent Operating Assets		 3.69 - - - 5.88 5.76 5.32 6.80 7.83 6.37
Total Liabilities & Shareholders' Equity		 613 493 423 411 476 506 564 624 727 769
Total Liabilities		 263 191 146 139 198 221 279 331 419 440
Total Current Liabilities		 259 186 142 135 192 216 274 328 415 436
Accounts Payable		 40 40 38 45 36 32 35 66 100 87
Accrued Expenses		 43 39 40 40 45 68 83 61 62 78
Other Current Liabilities		 176 107 64 49 111 116 156 200 254 271
Total Noncurrent Liabilities		 4.31 4.52 4.02 4.62 5.35 5.07 4.93 3.66 3.38 4.00
Other Noncurrent Operating Liabilities		 4.18 4.52 4.02 - 5.35 5.07 4.93 3.66 3.38 4.00
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 350 302 277 272 278 285 285 293 308 329
Total Preferred & Common Equity		 348 303 278 273 278 285 285 293 308 329
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 348 303 278 273 278 285 285 293 308 329
Common Stock		 160 162 163 164 164 165 166 167 168 171
Retained Earnings		 190 192 193 198 207 216 217 229 244 266
Treasury Stock		 - -47 -74 -84 -90 -92 -94 -98 -100 -103
Accumulated Other Comprehensive Income / (Loss)		 -1.81 -3.72 -4.40 -5.05 -2.47 -3.34 -4.65 -5.36 -4.08 -5.70

Annual Metrics and Ratios for Argan

This table displays calculated financial ratios and metrics derived from Argan's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/31/2015 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 68.43% 7.87% 63.34% 32.26% -46.00% -50.43% 64.11% 29.87% -10.67% 26.00% 52.47%
EBITDA Growth		 -7.08% 17.89% 53.27% -1.11% -55.64% -183.47% 168.43% 73.87% 0.46% 2.55% 121.12%
EBIT Growth		 -7.17% 17.31% 51.69% -1.67% -58.08% -201.16% 152.10% 89.12% -2.26% 6.38% 127.26%
NOPAT Growth		 5.05% 14.26% 53.39% -9.45% -35.68% -188.43% 156.37% 53.27% -6.91% -23.31% 181.13%
Net Income Growth		 0.26% 15.53% 54.22% -6.56% -28.30% -178.49% 158.49% 49.96% -2.81% -6.76% 164.10%
EPS Growth		 -26.26% 18.05% 85.95% 1.33% -27.19% -182.23% 155.31% 58.94% -2.92% 2.58% 157.32%
Operating Cash Flow Growth		 -5.16% -135.39% 884.22% -128.10% -54.30% 147.69% 228.60% -83.86% -205.79% 488.74% 43.41%
Free Cash Flow Firm Growth		 -12.11% -164.06% 551.14% -133.90% -50.93% 135.19% 271.87% -92.08% -382.93% 366.03% 18.39%
Invested Capital Growth		 -38.72% 66.52% -333.52% 67.07% 228.93% -86.54% -1,120.03% 15.15% 60.90% -172.58% -42.66%
Revenue Q/Q Growth		 12.59% 3.52% 15.46% -4.00% -14.52% -7.60% 14.36% 1.66% -1.47% 8.68% 8.42%
EBITDA Q/Q Growth		 -3.00% -11.54% 31.87% -15.33% -18.74% -19.17% 260.51% -19.41% 36.76% 13.40% 27.30%
EBIT Q/Q Growth		 -3.02% -12.12% 32.40% -15.83% -20.30% -16.89% 604.16% -20.60% 36.18% 11.26% 24.18%
NOPAT Q/Q Growth		 -0.27% -18.08% 38.55% -16.93% -18.82% -11.25% 808.53% -23.70% 79.37% -13.10% 36.52%
Net Income Q/Q Growth		 -0.36% -1.41% 17.66% -15.95% -15.26% -13.77% 238.13% -21.66% 81.30% -9.05% 29.27%
EPS Q/Q Growth		 -9.69% 2.54% 21.29% -14.93% -14.87% -12.81% 228.26% -16.08% 55.33% -3.24% 28.66%
Operating Cash Flow Q/Q Growth		 -40.44% 16.20% 30.39% -242.75% 24.70% 1,894.23% -2.34% -62.19% 65.16% -13.56% 13.57%
Free Cash Flow Firm Q/Q Growth		 -44.12% -26.01% 45.13% -313.51% 21.86% 728.98% -1.34% -78.85% 63.48% -22.39% 4.41%
Invested Capital Q/Q Growth		 2.77% 8.90% -29.45% 43.99% 15.49% -76.83% -19.32% 13.51% -333.89% -7.80% 2.42%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 21.82% 24.07% 21.73% 16.73% 17.10% -2.85% 15.83% 19.58% 18.98% 14.10% 16.13%
EBITDA Margin		 17.01% 18.59% 17.44% 13.04% 10.71% -18.04% 7.52% 10.07% 11.33% 9.22% 13.37%
Operating Margin		 16.74% 18.00% 16.63% 11.98% 8.35% -23.36% 5.87% 8.74% 9.16% 6.36% 10.09%
EBIT Margin		 16.80% 18.27% 16.97% 12.61% 9.79% -19.99% 6.34% 9.24% 10.11% 8.53% 12.72%
Profit (Net Income) Margin		 11.34% 12.15% 11.47% 8.10% 10.76% -17.03% 6.07% 7.01% 7.63% 5.64% 9.78%
Tax Burden Percent		 67.51% 66.49% 67.60% 64.24% 109.85% 85.23% 95.68% 75.87% 75.44% 66.13% 76.85%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 32.49% 33.51% 32.40% 35.76% -9.85% 0.00% 4.32% 24.13% 24.56% 33.87% 23.15%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 402.66% -70.42% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 400.56% -69.90% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% -388.88% 59.35% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 26.12% 25.30% 30.10% 22.24% 13.79% -11.07% 7.18% 11.02% 11.44% 11.32% 26.59%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% -132.39% 82.13% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 18.02% 18.85% 21.73% 18.97% 9.26% -9.91% 4.57% 8.14% 8.82% 9.00% 15.50%
Return on Assets (ROA)		 12.16% 12.54% 14.69% 12.19% 10.18% -8.44% 4.37% 6.18% 6.65% 5.95% 11.92%
Return on Common Equity (ROCE)		 26.83% 25.76% 29.85% 22.20% 13.79% -11.05% 7.14% 11.00% 11.46% 11.32% 26.59%
Return on Equity Simple (ROE_SIMPLE)		 23.43% 22.98% 26.55% 20.20% 13.15% -12.00% 7.43% 10.94% 12.35% 11.12% 24.29%
Net Operating Profit after Tax (NOPAT)		 43 49 76 69 44 -39 22 34 31 24 68
NOPAT Margin		 11.30% 11.97% 11.24% 7.70% 9.17% -16.36% 5.62% 6.63% 6.91% 4.21% 7.75%
Net Nonoperating Expense Percent (NNEP)		 0.05% 0.24% 0.39% 0.76% 2.10% -0.52% 0.45% 0.43% 0.85% 2.24% 3.77%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 11.19% 8.29% 19.26%
Cost of Revenue to Revenue		 78.18% 75.93% 78.27% 83.27% 82.90% 102.85% 84.17% 80.42% 81.02% 85.90% 83.87%
SG&A Expenses to Revenue		 5.08% 6.06% 4.81% 4.68% 8.44% 18.46% 9.95% 9.29% 9.82% 7.74% 6.04%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 5.08% 6.06% 5.10% 4.74% 8.75% 20.51% 9.95% 10.84% 9.82% 7.74% 6.04%
Earnings before Interest and Taxes (EBIT)		 64 76 115 113 47 -48 25 47 46 49 111
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 65 77 118 116 52 -43 30 51 52 53 117
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.84 1.61 3.10 1.54 1.40 1.67 1.94 1.68 1.81 2.00 5.28
Price to Tangible Book Value (P/TBV)		 2.07 2.05 3.64 1.74 1.55 1.85 2.16 1.86 2.03 2.24 5.77
Price to Revenue (P/Rev)		 0.89 0.85 1.34 0.62 1.14 2.37 1.59 1.08 1.12 1.02 2.12
Price to Earnings (P/E)		 11.21 9.68 12.87 7.66 10.61 0.00 26.12 14.34 15.37 18.01 21.73
Dividend Yield		 2.98% 2.95% 0.51% 2.82% 3.53% 2.76% 3.15% 2.87% 2.67% 2.52% 0.99%
Earnings Yield		 8.92% 10.33% 7.77% 13.05% 9.43% 0.00% 3.83% 6.98% 6.51% 5.55% 4.60%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 2.61 18.21 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.19 0.57 0.13 0.53 1.00 0.43 0.21 0.40 0.30 1.52
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 1.04 3.25 1.01 4.94 0.00 5.69 2.09 3.55 3.22 11.40
Enterprise Value to EBIT (EV/EBIT)		 0.00 1.06 3.34 1.05 5.41 0.00 6.75 2.27 3.98 3.48 11.98
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 1.62 5.05 1.71 5.78 0.00 7.62 3.17 5.83 7.06 19.65
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 1.48 0.00 0.00 4.48 0.95 3.77 0.00 1.46 7.95
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 1.51 0.00 0.00 5.26 0.99 7.97 0.00 1.69 11.14
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.82 -1.53 -1.55 -1.47 -0.97 -0.85 -1.18 -1.38 -1.26 -1.29 -1.46
Leverage Ratio		 2.15 2.02 2.05 1.82 1.35 1.31 1.64 1.78 1.72 1.90 2.23
Compound Leverage Factor		 2.15 2.02 2.05 1.82 1.35 1.31 1.64 1.78 1.72 1.90 2.23
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 -6.01% 1.51% 0.32% 0.01% -0.05% 0.52% 0.54% -0.24% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 106.01% 98.50% 99.68% 99.99% 100.05% 99.48% 99.46% 100.24% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 3.19 3.56 3.95 5.34 6.93 3.71 3.04 3.74 3.88 3.39 4.71
Noncontrolling Interest Sharing Ratio		 -2.72% -1.81% 0.83% 0.15% -0.02% 0.22% 0.53% 0.15% -0.13% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.69 1.87 1.68 2.65 5.12 2.93 1.98 2.27 2.17 1.81 1.63
Quick Ratio		 1.68 1.81 1.65 2.51 4.09 2.53 1.76 2.10 1.85 1.52 1.46
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 88 -56 253 -86 -130 46 170 13 -38 101 120
Operating Cash Flow to CapEx		 3,178.78% -1,059.40% 9,215.37% -1,508.35% -1,306.22% 758.93% 10,372.01% 1,998.24% -891.49% 4,240.13% 2,545.71%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.07 1.03 1.28 1.50 0.95 0.50 0.72 0.88 0.87 1.05 1.22
Accounts Receivable Turnover		 15.02 9.03 11.34 22.01 15.44 6.52 11.90 18.29 11.80 11.77 7.84
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 71.60 43.90 53.11 62.85 27.49 11.30 18.28 33.05 43.57 53.46 68.61
Accounts Payable Turnover		 9.94 7.46 7.12 7.35 5.71 6.53 7.44 8.61 7.51 10.28 10.72
Days Sales Outstanding (DSO)		 24.30 40.41 32.18 16.58 23.64 56.02 30.67 19.95 30.93 31.02 46.58
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 36.73 48.90 51.24 49.63 63.97 55.91 49.05 42.38 48.61 35.52 34.05
Cash Conversion Cycle (CCC)		 -12.43 -8.49 -19.06 -33.05 -40.33 0.11 -18.39 -22.42 -17.68 -4.50 12.54
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -159 -53 -230 -76 98 13 -134 -114 -45 -121 -173
Invested Capital Turnover		 -2.80 -3.90 -4.76 -5.83 43.92 4.31 -6.47 -4.10 -5.74 -6.91 -5.93
Increase / (Decrease) in Invested Capital		 -44 106 -177 155 174 -85 -147 20 69 -77 -52
Enterprise Value (EV)		 -2.93 80 383 118 255 240 168 107 183 170 1,332
Market Capitalization		 341 352 905 552 552 566 623 548 509 583 1,857
Book Value per Share		 $12.76 $14.74 $19.05 $23.03 $25.34 $21.70 $20.44 $20.77 $20.69 $21.83 $25.92
Tangible Book Value per Share		 $11.37 $11.59 $16.24 $20.36 $22.84 $19.59 $18.40 $18.77 $18.43 $19.56 $23.72
Total Capital		 175 222 293 358 394 341 322 326 281 291 352
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -334 -275 -523 -434 -297 -328 -457 -440 -325 -412 -525
Capital Expenditures (CapEx)		 2.94 3.12 2.81 4.83 8.60 7.06 1.70 1.42 3.37 2.76 6.58
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -185 -112 -286 -132 39 -50 -187 -156 -89 -167 -224
Debt-free Net Working Capital (DFNWC)		 149 163 237 302 335 278 270 284 236 245 301
Net Working Capital (NWC)		 149 163 237 302 335 278 270 284 236 245 301
Net Nonoperating Expense (NNE)		 -0.16 -0.73 -1.54 -3.63 -7.67 1.62 -1.78 -1.94 -3.27 -8.25 -18
Net Nonoperating Obligations (NNO)		 -334 -275 -523 -434 -297 -328 -457 -440 -325 -412 -525
Total Depreciation and Amortization (D&A)		 0.79 1.31 3.21 3.81 4.43 4.65 4.62 4.24 5.54 3.92 5.66
Debt-free, Cash-free Net Working Capital to Revenue		 -48.23% -27.13% -42.33% -14.81% 7.99% -20.98% -47.58% -30.67% -19.62% -29.21% -25.59%
Debt-free Net Working Capital to Revenue		 38.87% 39.42% 35.14% 33.80% 69.49% 116.20% 68.88% 55.81% 51.91% 42.72% 34.48%
Net Working Capital to Revenue		 38.87% 39.42% 35.14% 33.80% 69.49% 116.20% 68.88% 55.81% 51.91% 42.72% 34.48%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.11 $2.46 $4.67 $4.64 $3.34 ($2.73) $1.52 $2.43 $2.35 $2.42 $6.35
Adjusted Weighted Average Basic Shares Outstanding		 14.43M 14.76M 15.07M 15.52M 15.57M 15.62M 15.67M 15.72M 14.08M 13.37M 13.45M
Adjusted Diluted Earnings per Share		 $2.05 $2.42 $4.50 $4.56 $3.32 ($2.73) $1.51 $2.40 $2.33 $2.39 $6.15
Adjusted Weighted Average Diluted Shares Outstanding		 14.82M 15.02M 15.63M 15.78M 15.69M 15.62M 15.83M 15.91M 14.18M 13.55M 13.91M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 14.63M 14.84M 15.47M 15.57M 15.58M 15.64M 15.72M 14.82M 13.40M 13.24M 13.63M
Normalized Net Operating Profit after Tax (NOPAT)		 43 49 77 69 29 -36 22 40 31 24 68
Normalized NOPAT Margin		 11.30% 11.97% 11.44% 7.74% 6.06% -14.92% 5.62% 7.81% 6.91% 4.21% 7.75%
Pre Tax Income Margin		 16.80% 18.27% 16.97% 12.61% 9.79% -19.99% 6.34% 9.24% 10.11% 8.53% 12.72%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 80.93% 20.67% 31.98% 23.19% 30.16% -38.37% 197.59% 43.87% 42.17% 45.38% 21.38%
Augmented Payout Ratio		 80.93% 20.67% 31.98% 23.19% 30.16% -38.37% 197.59% 100.92% 238.79% 83.90% 23.16%

Quarterly Metrics and Ratios for Argan

This table displays calculated financial ratios and metrics derived from Argan's official financial filings.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 7/31/2022 10/31/2022 1/31/2023 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -11.20% -5.28% -5.41% 3.39% 19.68% 38.92% 38.54% 52.09% 60.61% 56.95% 41.28%
EBITDA Growth		 -17.95% -32.60% 1,727.31% -66.00% 20.53% 8.16% 30.18% 225.84% 38.43% 207.96% 123.41%
EBIT Growth		 -18.48% -34.18% 6,266.67% -69.22% 24.81% 12.46% 41.18% 276.60% 39.88% 218.97% 127.55%
NOPAT Growth		 -68.86% -37.61% 1,569.52% -63.71% 139.35% -48.40% -31.51% 78.07% 43.74% 520.20% 219.61%
Net Income Growth		 -67.20% -37.40% 4,817.96% -71.82% 202.39% -29.57% -21.14% 273.73% 42.54% 412.63% 161.02%
EPS Growth		 -62.96% -28.21% 592.86% -68.00% 213.33% -28.57% -8.25% 262.50% 39.36% 400.00% 153.93%
Operating Cash Flow Growth		 -157.13% -195.57% 423.15% 96.86% 310.03% 455.97% -42.71% 1,517.15% 105.29% -44.93% 81.44%
Free Cash Flow Firm Growth		 -230.29% -472.23% -170.57% 62.27% 127.80% 192.83% 248.72% 470.86% 343.09% -17.19% -8.06%
Invested Capital Growth		 72.21% 92.21% 60.90% 40.45% -46.31% -997.20% -172.58% -216.00% -187.74% -57.59% -42.66%
Revenue Q/Q Growth		 17.78% -0.20% 0.77% -12.72% 36.34% 15.85% 0.49% -4.18% 43.97% 13.21% -9.55%
EBITDA Q/Q Growth		 38.71% -24.36% 30.14% -71.57% 391.78% -32.13% 56.63% -32.30% 108.93% 50.99% 13.63%
EBIT Q/Q Growth		 42.53% -25.88% 16.65% -75.02% 477.86% -33.22% 46.44% -33.36% 114.63% 52.29% 4.47%
NOPAT Q/Q Growth		 -42.11% 76.47% 68.77% -78.95% 281.81% -61.96% 124.03% -45.27% 208.19% 64.14% 15.45%
Net Income Q/Q Growth		 -43.59% 83.75% 96.43% -86.16% 505.36% -57.20% 119.95% -34.42% 130.88% 53.92% 11.99%
EPS Q/Q Growth		 -40.00% 86.67% 73.21% -83.51% 487.50% -57.45% 122.50% -34.83% 125.86% 52.67% 13.00%
Operating Cash Flow Q/Q Growth		 57.10% 4.89% 364.79% -102.91% 2,968.67% 61.20% -57.38% -28.09% 315.55% -56.76% 40.42%
Free Cash Flow Firm Q/Q Growth		 -65.41% -8.95% 49.89% 58.23% 221.87% 263.83% -19.71% 4.17% 45.61% -32.01% -10.85%
Invested Capital Q/Q Growth		 35.92% 75.52% -333.89% 12.51% -57.43% -83.58% -7.80% -1.43% -43.35% -0.55% 2.42%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 20.65% 18.84% 16.86% 13.72% 16.80% 11.75% 14.36% 11.38% 13.70% 17.25% 20.48%
EBITDA Margin		 12.61% 9.55% 12.34% 3.52% 12.70% 7.44% 11.59% 7.54% 10.94% 14.59% 18.33%
Operating Margin		 11.35% 8.09% 8.05% 3.50% 9.37% 4.80% 7.12% 4.13% 8.23% 11.80% 14.05%
EBIT Margin		 11.78% 8.75% 10.12% 2.90% 12.28% 7.08% 10.32% 7.17% 10.70% 14.39% 16.62%
Profit (Net Income) Margin		 3.57% 6.58% 12.83% 2.03% 9.03% 3.34% 7.30% 5.00% 8.02% 10.90% 13.49%
Tax Burden Percent		 30.36% 75.25% 126.73% 70.21% 73.55% 47.13% 70.79% 69.67% 74.95% 75.75% 81.20%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 69.64% 24.75% -26.73% 29.79% 26.45% 52.87% 29.21% 30.33% 25.05% 24.25% 18.80%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 7.70% 6.16% 11.44% 10.11% 13.48% 12.79% 11.32% 13.35% 14.69% 21.55% 26.59%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 10.26% 7.89% 8.83% 2.74% 12.74% 7.66% 10.88% 8.18% 12.38% 17.41% 20.25%
Return on Assets (ROA)		 3.12% 5.94% 11.19% 1.93% 9.37% 3.61% 7.70% 5.70% 9.28% 13.19% 16.45%
Return on Common Equity (ROCE)		 7.69% 6.15% 11.46% 10.13% 13.50% 12.80% 11.32% 13.35% 14.69% 21.55% 26.59%
Return on Equity Simple (ROE_SIMPLE)		 8.56% 7.02% 0.00% 10.55% 13.29% 12.49% 0.00% 13.01% 14.14% 20.11% 0.00%
Net Operating Profit after Tax (NOPAT)		 4.07 7.18 12 2.55 9.74 3.70 8.30 4.54 14 23 27
NOPAT Margin		 3.44% 6.09% 10.20% 2.46% 6.89% 2.26% 5.04% 2.88% 6.17% 8.94% 11.41%
Net Nonoperating Expense Percent (NNEP)		 0.04% 0.15% 0.82% -0.13% 0.91% 0.52% 1.01% 0.91% 1.01% 1.11% 1.03%
Return On Investment Capital (ROIC_SIMPLE)		 - - 4.31% - - - 2.85% - - - 7.54%
Cost of Revenue to Revenue		 79.35% 81.16% 83.14% 86.28% 83.20% 88.25% 85.64% 88.62% 86.30% 82.75% 79.52%
SG&A Expenses to Revenue		 9.30% 10.75% 8.81% 10.22% 7.43% 6.95% 7.24% 7.25% 5.47% 5.45% 6.43%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 9.30% 10.75% 8.81% 10.22% 7.43% 6.95% 7.24% 7.25% 5.47% 5.45% 6.43%
Earnings before Interest and Taxes (EBIT)		 14 10 12 3.00 17 12 17 11 24 37 39
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 15 11 15 3.65 18 12 19 12 25 38 43
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.81 1.69 1.81 1.88 1.75 2.10 2.00 2.71 3.42 5.42 5.28
Price to Tangible Book Value (P/TBV)		 2.04 1.91 2.03 2.12 1.96 2.35 2.24 3.02 3.79 5.97 5.77
Price to Revenue (P/Rev)		 1.07 1.00 1.12 1.14 1.04 1.13 1.02 1.27 1.48 2.21 2.12
Price to Earnings (P/E)		 19.61 22.70 15.37 18.62 13.68 17.83 18.01 22.10 24.21 27.10 21.73
Dividend Yield		 2.83% 3.01% 2.67% 2.56% 2.69% 2.34% 2.52% 1.92% 1.52% 0.97% 0.99%
Earnings Yield		 5.10% 4.41% 6.51% 5.37% 7.31% 5.61% 5.55% 4.53% 4.13% 3.69% 4.60%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.39 0.38 0.40 0.45 0.32 0.38 0.30 0.60 0.80 1.58 1.52
Enterprise Value to EBITDA (EV/EBITDA)		 4.24 4.63 3.55 4.85 3.34 4.30 3.22 6.35 8.57 13.90 11.40
Enterprise Value to EBIT (EV/EBIT)		 4.67 5.16 3.98 5.27 3.57 4.56 3.48 6.61 8.87 14.25 11.98
Enterprise Value to NOPAT (EV/NOPAT)		 8.37 9.95 5.83 7.66 4.78 7.23 7.06 14.44 18.73 25.71 19.65
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 24.56 2.49 1.48 1.46 2.79 3.28 8.65 7.95
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 395.34 2.97 1.54 1.69 3.43 3.91 11.14 11.14
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.31 -1.23 -1.26 -1.18 -1.18 -1.22 -1.29 -1.28 -1.40 -1.47 -1.46
Leverage Ratio		 1.74 1.65 1.72 1.67 1.65 1.75 1.90 1.93 2.08 2.17 2.23
Compound Leverage Factor		 1.74 1.65 1.72 1.67 1.65 1.75 1.90 1.93 2.08 2.17 2.23
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 -0.29% -0.29% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.29% 100.29% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 4.59 4.54 3.65 3.77 3.59 3.34 3.21 3.49 3.50 4.56 4.42
Noncontrolling Interest Sharing Ratio		 0.15% 0.15% -0.13% -0.14% -0.14% -0.14% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.66 2.71 2.17 2.21 2.11 1.88 1.81 1.75 1.63 1.64 1.63
Quick Ratio		 2.42 2.41 1.85 1.96 1.81 1.63 1.52 1.45 1.40 1.46 1.46
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -105 -114 -57 -24 29 106 85 89 129 88 78
Operating Cash Flow to CapEx		 -4,261.50% -833.95% 5,433.80% -193.49% 9,274.87% 5,189.75% 4,012.23% 5,492.55% 3,128.78% 1,247.70% 3,269.16%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.87 0.90 0.87 0.95 1.04 1.08 1.05 1.14 1.16 1.21 1.22
Accounts Receivable Turnover		 13.78 12.53 11.80 9.47 13.88 12.01 11.77 10.39 10.20 8.88 7.84
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 32.62 31.97 43.57 44.51 48.25 49.56 53.46 58.38 63.22 64.67 68.61
Accounts Payable Turnover		 9.11 8.76 7.51 9.90 11.52 11.29 10.28 10.56 9.47 11.33 10.72
Days Sales Outstanding (DSO)		 26.50 29.12 30.93 38.54 26.30 30.38 31.02 35.12 35.80 41.10 46.58
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 40.05 41.67 48.61 36.87 31.69 32.34 35.52 34.56 38.56 32.20 34.05
Cash Conversion Cycle (CCC)		 -13.55 -12.55 -17.68 1.68 -5.39 -1.96 -4.50 0.56 -2.76 8.90 12.54
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -42 -10 -45 -39 -61 -113 -121 -123 -177 -178 -173
Invested Capital Turnover		 -4.86 -6.50 -5.74 -8.78 -9.32 -8.58 -6.91 -7.74 -5.99 -5.56 -5.93
Increase / (Decrease) in Invested Capital		 109 121 69 26 -19 -102 -77 -84 -115 -65 -52
Enterprise Value (EV)		 183 174 183 207 153 201 170 378 569 1,276 1,332
Market Capitalization		 503 462 509 524 499 598 583 795 1,054 1,782 1,857
Book Value per Share		 $19.56 $19.63 $20.69 $20.75 $21.25 $21.39 $21.83 $22.14 $23.07 $24.35 $25.92
Tangible Book Value per Share		 $17.38 $17.41 $18.43 $18.47 $18.98 $19.11 $19.56 $19.86 $20.82 $22.13 $23.72
Total Capital		 277 272 281 278 285 285 291 293 308 329 352
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -319 -287 -325 -317 -346 -398 -412 -416 -485 -506 -525
Capital Expenditures (CapEx)		 0.40 1.94 0.79 0.65 0.39 1.11 0.61 0.32 2.35 2.55 1.37
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -83 -56 -89 -84 -107 -157 -167 -170 -225 -225 -224
Debt-free Net Working Capital (DFNWC)		 236 230 236 233 240 240 245 247 260 281 301
Net Working Capital (NWC)		 236 230 236 233 240 240 245 247 260 281 301
Net Nonoperating Expense (NNE)		 -0.15 -0.58 -3.12 0.44 -3.03 -1.76 -3.72 -3.34 -4.20 -5.03 -4.84
Net Nonoperating Obligations (NNO)		 -319 -282 -325 -317 -346 -398 -412 -416 -485 -506 -525
Total Depreciation and Amortization (D&A)		 0.98 0.95 2.63 0.65 0.59 0.59 2.10 0.58 0.56 0.53 3.99
Debt-free, Cash-free Net Working Capital to Revenue		 -17.68% -12.17% -19.62% -18.40% -22.19% -29.82% -29.21% -27.04% -31.54% -27.94% -25.59%
Debt-free Net Working Capital to Revenue		 50.42% 49.89% 51.91% 50.74% 49.73% 45.53% 42.72% 39.33% 36.44% 34.85% 34.48%
Net Working Capital to Revenue		 50.42% 49.89% 51.91% 50.74% 49.73% 45.53% 42.72% 39.33% 36.44% 34.85% 34.48%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.30 $0.56 $0.99 $0.16 $0.95 $0.41 $0.90 $0.59 $1.36 $2.07 $2.33
Adjusted Weighted Average Basic Shares Outstanding		 14.13M 13.78M 14.08M 13.41M 13.40M 13.33M 13.37M 13.26M 13.40M 13.53M 13.45M
Adjusted Diluted Earnings per Share		 $0.30 $0.56 $0.97 $0.16 $0.94 $0.40 $0.89 $0.58 $1.31 $2.00 $2.26
Adjusted Weighted Average Diluted Shares Outstanding		 14.25M 13.81M 14.18M 13.55M 13.54M 13.56M 13.55M 13.57M 13.88M 14.03M 13.91M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.88M 13.58M 13.40M 13.41M 13.32M 13.33M 13.24M 13.35M 13.50M 13.58M 13.63M
Normalized Net Operating Profit after Tax (NOPAT)		 9.38 7.18 6.69 2.55 9.74 5.50 8.30 4.54 14 23 27
Normalized NOPAT Margin		 7.94% 6.09% 5.64% 2.46% 6.89% 3.36% 5.04% 2.88% 6.17% 8.94% 11.41%
Pre Tax Income Margin		 11.78% 8.75% 10.12% 2.90% 12.28% 7.08% 10.32% 7.17% 10.70% 14.39% 16.62%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 62.97% 75.34% 42.17% 48.68% 37.34% 41.40% 45.38% 40.26% 36.85% 26.11% 21.38%
Augmented Payout Ratio		 372.26% 512.20% 238.79% 201.58% 94.91% 79.21% 83.90% 63.78% 50.42% 33.13% 23.16%

Frequently Asked Questions About Argan's Financials

When does Argan's fiscal year end?

According to the most recent income statement we have on file, Argan's financial year ends in January. Their financial year 2025 ended on January 31, 2025.

How has Argan's net income changed over the last 10 years?

Over the last 10 years, Argan's net income changed from $43.46 million in 2015 to $85.46 million in 2025, a change of 96.7%. View Argan's forecast to see where analysts expect Argan to go next.

What is Argan's operating income?
Argan's total operating income in 2025 was $88.20 million, based on the following breakdown:
  • Total Gross Profit: $140.99 million
  • Total Operating Expenses: $52.79 million
How has Argan revenue changed over the last 10 years?

Over the last 10 years, Argan's total revenue changed from $383.11 million in 2015 to $874.18 million in 2025, a change of 128.2%.

How much debt does Argan have?

Argan's total liabilities were at $484.37 million at the end of 2025, a 57.6% increase from 2024, and a 124.0% increase since 2015.

How much cash does Argan have?

In the past 10 years, Argan's cash and equivalents has ranged from $122.11 million in 2018 to $366.67 million in 2021, and is currently $145.26 million as of their latest financial filing in 2025.

How has Argan's book value per share changed over the last 10 years?

Over the last 10 years, Argan's book value per share changed from 12.76 in 2015 to 25.92 in 2025, a change of 103.1%.


Related Companies

This page (NYSE:AGX) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...
Timothy Sykes | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
DOGE officially begins retirement transformation
Elon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...
Altimetry | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...
Weiss Ratings | Sponsored
If you missed your chance with Tesla...
Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...
Brownstone Research | Sponsored
Will May start the next "Great Depression?"
You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...
Behind the Markets | Sponsored
🥾⛏️👷‍♂️ What I Learned From Numerous Mine Visits...
Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...
Golden Portfolio | Sponsored
The Last Time This Happened, Americans Lost Billions
Wall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...
Banyan Hill Publishing | Sponsored